From theheart.org on Medscape

Coverage from the

American College of Cardiology (ACC) 2022 Scientific Session

April 02 - 04, 2022; Washington, DC, and Virtual

April 02 - 04, 2022 Washington, DC, and Virtual

ACC 2022 APOLLO: SLN360 Clears First Major Hurdle, Hammering Lp(a) The results add to growing enthusiasm for achieving the 'holy grail' of a lipoprotein(a)-specific lowering agent, but whether it will reduce cardiovascular risk remains unknown.
Medscape Medical News, April 3, 2022
ACC 2022 Supermarket Diet Advice Improves DASH Adherence: SuperWIN People who received personalized nutrition education at the grocery store significantly improved adherence to a healthy diet, in a study where researchers partnered with a large supermarket company.
Medscape Medical News, April 3, 2022
ACC 2022 VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in OHCM A medical alternative to highly invasive septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy and symptoms despite standard meds? Perhaps, a randomized trial suggests.
Medscape Medical News, April 2, 2022

Conference News

ACC 2022 FFR Not Better, Just Different From IVUS for PCI
Medscape Medical News, April 14, 2022
ACC 2022 Empagliflozin Rapidly Improves Acute Heart Failure Symptoms
Medscape Medical News, April 14, 2022
ACC 2022 BIO-GUARD-MI Questions Post-MI Therapy Guided by Rhythm Monitor
Medscape Medical News, April 13, 2022
ACC 2022 Alerts Improve Prescribing of HF Quadruple Therapy: PROMPT-HF
Medscape Medical News, April 13, 2022
ACC 2022 TAVI Valve Shows Less Deterioration Than Surgery at 5 Years
Medscape Medical News, April 12, 2022
ACC 2022 New Smart Device Shows Highly Accurate AF Detection: mAFA II
Medscape Medical News, April 12, 2022
ACC 2022 VT Ablation After First ICD Shock Boosts Survival: PARTITA
Medscape Medical News, April 11, 2022
ACC 2022 Renal Denervation BP Benefits Remain at 3 Years: SPYRAL HTN-ON
Medscape Medical News, April 8, 2022
ACC 2022 Sweet Success for Chocolate Touch DCB in Femoropopliteal Disease
Medscape Medical News, April 8, 2022
ACC 2022 QOL Improves With Complete Revascularization After STEMI
Medscape Medical News, April 8, 2022
ACC 2022 ACC Treatment Initiative Improves International STEMI Care
Medscape Medical News, April 7, 2022
ACC 2022 Extraction of Infected Implanted Cardiac Devices Rare
Medscape Medical News, April 7, 2022
ACC 2022 PROTECT Questions Hypothermia Prevention at Noncardiac Surgery
Medscape Medical News, April 6, 2022
ACC 2022 Small Leaks After LAAO Linked to Thromboembolism, Bleeding
Medscape Medical News, April 6, 2022
ACC 2022 Less Bleeding With Factor XI Inhibitor Anticoagulant? PACIFIC-AF
Medscape Medical News, April 6, 2022
ACC 2022 More Encouraging Data on Ticagrelor Reversal Agent
Medscape Medical News, April 5, 2022
ACC 2022 Flu Vaccines Cut Seasonal Death in Patients With Heart Failure
Medscape Medical News, April 5, 2022
ACC 2022 DIAMOND: Patiromer Helps Optimize HF Meds, Foils Hyperkalemia
Medscape Medical News, April 5, 2022
ACC 2022 Pascal Tricuspid Repair Outcomes Durable at 1 Year: CLASP-TR
Medscape Medical News, April 5, 2022

ACC 2022 Early PCSK9 Inhibition in AMI Yields Plaque Regression
Medscape Medical News, April 5, 2022
ACC 2022 Anticoagulation Not Routinely Needed After TAVR: ADAPT-TAVR
Medscape Medical News, April 4, 2022
ACC 2022 Mavacamten Controlled Hypertrophic Cardiomyopathy for >1 Year
Medscape Medical News, April 3, 2022
ACC 2022 New HF Guidelines Feature 'Quad' Therapy, Tweaked Terminology
Medscape Medical News, April 3, 2022
ACC 2022 APOLLO: SLN360 Clears First Major Hurdle, Hammering Lp(a)
Medscape Medical News, April 3, 2022
ACC 2022 FAME 3 Subanalysis Adds Twist to Negative Primary Results
Medscape Medical News, April 3, 2022
ACC 2022 Supermarket Diet Advice Improves DASH Adherence: SuperWIN
Medscape Medical News, April 3, 2022
ACC 2022 Diltiazem Fails to Improve Vasomotor Dysfunction, Angina in ANOCA
Medscape Medical News, April 3, 2022
ACC 2022 Novel Cholesterol Drug Disappoints: TRANSLATE-TIMI 70
Medscape Medical News, April 3, 2022
ACC 2022 SCORED Trial: Sotagliflozin Showed Robust MACE Benefit
Medscape Medical News, April 2, 2022
ACC 2022 Hypertension Control During Pregnancy Validated in Large Trial
Medscape Medical News, April 2, 2022
ACC 2022 VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in OHCM
Medscape Medical News, April 2, 2022
ACC 2022 POISE-3 Backs Wider Use of TXA in Noncardiac Surgery
Medscape Medical News, April 2, 2022
ACC 2022 Low-Sodium Diet Did Not Cut Clinical Events in Heart Failure
Medscape Medical News, April 2, 2022
ACC 2022 Exercise Provides Twice the CV Benefit in Anxiety, Depression
Medscape Medical News, April 1, 2022
ACC 2022 'Voice Biomarker' Shows Progress in CAD Risk Assessment
Medscape Medical News, March 31, 2022
ACC 2022 Hybrid ACC.22 Resurrects the Live Scientific Session
Medscape Medical News, March 28, 2022
ACC 2022 Calcium Scores May Predict Sudden-Death Risk in Preclinical CAD
Medscape Medical News, March 28, 2022
ACC 2022 Coffee Drinking May Cut Heart Disease Risk, Prolong Survival
Medscape Medical News, March 27, 2022

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Making Healthy (Plant-Based) Diets the Easy Choice
Michelle L. O'Donoghue, MD, MPH; Robert J. Ostfeld, MD
Diabetes and Heart Disease Highlights From ACC 2022
Martha Gulati, MD
Top Abstracts in Atherosclerosis and Lipid Management From ACC 2022
Deepak Bhatt, MD, MPH
SODIUM-HF Simplifies Message to Patients on Diet
Ileana L. Piña, MD, MPH; Justin A. Ezekowitz, MBBCh, MSc
Sodium Restriction in Heart Failure: Another Dogma Felled
John M. Mandrola, MD
Benefit of SubQ Arrhythmia Monitoring Post-MI May Hinge on Risk: BIO|GUARD-MI
Jagmeet P. Singh, MD, MSc, DPhil; Christian Jøns, MD, PhD
SuperWIN: Supermarket Partnership Improves DASH Diet Score
Michelle L. O'Donoghue, MD, MPH; Dylan L. Steen, MD
Mavacamten in HCM: Reasons for Optimism and Caution
John M. Mandrola, MD
Mandrola Previews ACC 2022
John M. Mandrola, MD

Popular News from ACC 2021

PARADISE-MI: Sacubitril/Valsartan Can’t Beat Ramipril in Acute MI Sacubitril/valsartan came suggestively close to showing efficacy for preventing cardiovascular death or heart failure events in patients with acute MI but no history of heart failure.
Medscape Medical News, May 15, 2021
LAAOS III: Surgical LAA Closure Cuts AF Stroke Risk by One Third The finding 'opens a new paradigm' for stroke prevention in atrial fibrillation and should change clinical guidelines, experts say.
Medscape Medical News, May 15, 2021
ADAPTABLE: Low-Dose Aspirin as Good as High-Dose in CHD? A large randomized trial specifically designed to investigate the optimum dose of aspirin in patients with established coronary disease has found similar efficacy and safety with 81 mg and 325 mg.
Medscape Medical News, May 15, 2021

Previous Coverage

Related Resource